| Product Code: ETC12953839 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Multiple Sclerosis Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Multiple Sclerosis Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Multiple Sclerosis Market - Industry Life Cycle |
3.4 Israel Multiple Sclerosis Market - Porter's Five Forces |
3.5 Israel Multiple Sclerosis Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Multiple Sclerosis Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Israel Multiple Sclerosis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 Israel Multiple Sclerosis Market Revenues & Volume Share, By Symptom Management, 2021 & 2031F |
3.9 Israel Multiple Sclerosis Market Revenues & Volume Share, By Stage, 2021 & 2031F |
4 Israel Multiple Sclerosis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of multiple sclerosis in Israel |
4.2.2 Advancements in treatment options and therapies for multiple sclerosis |
4.2.3 Growing awareness and diagnosis rates of multiple sclerosis in Israel |
4.3 Market Restraints |
4.3.1 High cost of multiple sclerosis medications and treatments |
4.3.2 Limited access to specialized healthcare services for multiple sclerosis patients in certain regions of Israel |
5 Israel Multiple Sclerosis Market Trends |
6 Israel Multiple Sclerosis Market, By Types |
6.1 Israel Multiple Sclerosis Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Multiple Sclerosis Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Israel Multiple Sclerosis Market Revenues & Volume, By Relapsing-Remitting MS, 2021 - 2031F |
6.1.4 Israel Multiple Sclerosis Market Revenues & Volume, By Secondary Progressive MS, 2021 - 2031F |
6.1.5 Israel Multiple Sclerosis Market Revenues & Volume, By Primary Progressive MS, 2021 - 2031F |
6.1.6 Israel Multiple Sclerosis Market Revenues & Volume, By Clinically Isolated Syndrome, 2021 - 2031F |
6.1.7 Israel Multiple Sclerosis Market Revenues & Volume, By Pediatric MS, 2021 - 2031F |
6.2 Israel Multiple Sclerosis Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 Israel Multiple Sclerosis Market Revenues & Volume, By MRI, 2021 - 2031F |
6.2.3 Israel Multiple Sclerosis Market Revenues & Volume, By Lumbar Puncture, 2021 - 2031F |
6.2.4 Israel Multiple Sclerosis Market Revenues & Volume, By Evoked Potentials, 2021 - 2031F |
6.2.5 Israel Multiple Sclerosis Market Revenues & Volume, By Blood Tests, 2021 - 2031F |
6.2.6 Israel Multiple Sclerosis Market Revenues & Volume, By Neurological Exam, 2021 - 2031F |
6.3 Israel Multiple Sclerosis Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 Israel Multiple Sclerosis Market Revenues & Volume, By Immunomodulators, 2021 - 2031F |
6.3.3 Israel Multiple Sclerosis Market Revenues & Volume, By Corticosteroids, 2021 - 2031F |
6.3.4 Israel Multiple Sclerosis Market Revenues & Volume, By Physical Therapy, 2021 - 2031F |
6.3.5 Israel Multiple Sclerosis Market Revenues & Volume, By Occupational Therapy, 2021 - 2031F |
6.3.6 Israel Multiple Sclerosis Market Revenues & Volume, By Disease-Modifying Therapies, 2021 - 2031F |
6.4 Israel Multiple Sclerosis Market, By Symptom Management |
6.4.1 Overview and Analysis |
6.4.2 Israel Multiple Sclerosis Market Revenues & Volume, By Fatigue Management, 2021 - 2031F |
6.4.3 Israel Multiple Sclerosis Market Revenues & Volume, By Pain Relief, 2021 - 2031F |
6.4.4 Israel Multiple Sclerosis Market Revenues & Volume, By Muscle Spasticity, 2021 - 2031F |
6.4.5 Israel Multiple Sclerosis Market Revenues & Volume, By Cognitive Therapy, 2021 - 2031F |
6.4.6 Israel Multiple Sclerosis Market Revenues & Volume, By Emotional Support, 2021 - 2031F |
6.5 Israel Multiple Sclerosis Market, By Stage |
6.5.1 Overview and Analysis |
6.5.2 Israel Multiple Sclerosis Market Revenues & Volume, By Early Stage, 2021 - 2031F |
6.5.3 Israel Multiple Sclerosis Market Revenues & Volume, By Progressive Stage, 2021 - 2031F |
6.5.4 Israel Multiple Sclerosis Market Revenues & Volume, By Advanced Stage, 2021 - 2031F |
6.5.5 Israel Multiple Sclerosis Market Revenues & Volume, By Late Stage, 2021 - 2031F |
6.5.6 Israel Multiple Sclerosis Market Revenues & Volume, By Pediatric Stage, 2021 - 2031F |
7 Israel Multiple Sclerosis Market Import-Export Trade Statistics |
7.1 Israel Multiple Sclerosis Market Export to Major Countries |
7.2 Israel Multiple Sclerosis Market Imports from Major Countries |
8 Israel Multiple Sclerosis Market Key Performance Indicators |
8.1 Number of healthcare facilities offering specialized multiple sclerosis treatments |
8.2 Percentage of multiple sclerosis patients receiving timely diagnosis and treatment |
8.3 Research and development investments in innovative therapies for multiple sclerosis in Israel |
9 Israel Multiple Sclerosis Market - Opportunity Assessment |
9.1 Israel Multiple Sclerosis Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Multiple Sclerosis Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 Israel Multiple Sclerosis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 Israel Multiple Sclerosis Market Opportunity Assessment, By Symptom Management, 2021 & 2031F |
9.5 Israel Multiple Sclerosis Market Opportunity Assessment, By Stage, 2021 & 2031F |
10 Israel Multiple Sclerosis Market - Competitive Landscape |
10.1 Israel Multiple Sclerosis Market Revenue Share, By Companies, 2024 |
10.2 Israel Multiple Sclerosis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here